Source:http://linkedlifedata.com/resource/pubmed/id/12235522
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2002-9-17
|
| pubmed:abstractText |
Graft-versus-host disease (GVHD) is a major complication after hemopoietic stem cell transplantation (HSCT), but its pathogenesis remains uncertain. Macrophage migratory inhibitory factor (MIF) is an important mediator in the allo-immune reaction during renal transplantation, yet its role in hemopoietic stem cell transplantation (HSCT) remains unexplored. This study investigated the potential role of MIF in acute graft-versus-host disease (aGVHD) following allogeneic HSCT. Forty-six randomly selected patients undergoing autologous or allogeneic HSCT were studied. Immunohistochemistry and in situ hybridization were performed to examine tissue MIF mRNA and protein expression on skin and colonic biopsy specimens. The associated T cell and macrophage activation was also studied by immunohistochemical studies. A semi-quantitative method was used to assess MIF staining, as well as T cell and macrophage staining. Serial blood samples were analyzed by ELISA for serum MIF levels. Immunohistochemistry and in situ hybridization performed in 15 skin and 19 colonic biopsies from 17 patients who developed moderate to severe aGVHD showed a significant increase in MIF mRNA and protein expression compared with normal controls (seven skin and five colonic biopsies). MIF was localized within the epidermis and the vascular area of skin, but diffusely expressed in the entire thickness of colon. Macrophage and T lymphocyte infiltration was confined to areas of strong MIF expression. Serial analysis by ELISA showed that only patients who developed aGVHD (n = 19) exhibited an increase (two- to three-fold) in serum MIF during HSCT, but not in the allogeneic HSCT recipients without aGVHD (n = 7) or those who received autologous HSCT (n = 8). In 14 out of 19 patients, serum MIF peaked before the onset of aGVHD. Local and systemic up-regulation of MIF expression is associated with the occurrence of acute GVHD. Its pathogenetic role remains to be further determined.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0268-3369
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
30
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
375-80
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:12235522-Acute Disease,
pubmed-meshheading:12235522-Adult,
pubmed-meshheading:12235522-Cell Movement,
pubmed-meshheading:12235522-Colon,
pubmed-meshheading:12235522-Female,
pubmed-meshheading:12235522-Graft vs Host Disease,
pubmed-meshheading:12235522-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:12235522-Humans,
pubmed-meshheading:12235522-Immunohistochemistry,
pubmed-meshheading:12235522-Macrophage Migration-Inhibitory Factors,
pubmed-meshheading:12235522-Macrophages,
pubmed-meshheading:12235522-Male,
pubmed-meshheading:12235522-Middle Aged,
pubmed-meshheading:12235522-RNA, Messenger,
pubmed-meshheading:12235522-Skin,
pubmed-meshheading:12235522-T-Lymphocytes,
pubmed-meshheading:12235522-Transplantation, Homologous,
pubmed-meshheading:12235522-Up-Regulation
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
|
| pubmed:affiliation |
Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|